Exhibit 10(ccc)
--------------------------------------------------------------------------------
AWARD/CONTRACT 1. THIS CONTRACT IS A RATED ORDER RATING PAGE OF PAGES
UNDER DPAS (15 CFR 350) 1 20
--------------------------------------------------------------------------------
2. CONTRACT (Proc. Inst. Ident.) NO. 3. EFFECTIVE DATE
DAMD17-03-C-0040 01 Jan 2003
--------------------------------------------------------------------------------
4. REQUISITION/PURCHASE REQUEST/PROJECT NO.
W23RYX-2331-N643
--------------------------------------------------------------------------------
5. ISSUED BY CODE DAMD17 6. ADMINISTERED BY CODE
---------- (If other than Item 5.) ------
USA MED RESEARCH ACQ ACTIVITY
DIRECTOR 000 XXXXXXXX XXXXXX See Item 5
FORT XXXXXXX MD 21702-5014
--------------------------------------------------------------------------------
7. NAME AND ADDRESS OF CONTRACTOR 8. DELIVERY
(No., street, city, country, state |_| FOB ORIGIN |X| OTHER (See below)
and zip code) ----------------------------------------
9. DISCOUNT FOR PROMPT PAYMENT
SIGA TECHNOLOGIES INC.
XXXXXX X. XXXXX, PH.D. Net 30 Days
0000 XX XXXXXXXX XXX
XXXXX 230 ----------------------------------------
CORVALLIS OR 97333 10. SUBMIT INVOICES 1 ITEM
(4 copies unless
otherwise specified) Block 12
----------------------------------------TO THE ADDRESS
CODE 1V4X4 FACILITY CODE SHOWN IN:
--------------------------------------------------------------------------------
11. SHIP TO/MARK FOR CODE 12. PAYMENT WILL BE MADE BY CODE HQ0345
---------- ------
USA MED RESEARCH AND MATERIELCOM DEFENSE FINANCE AND ACCOUNTING SERVICE
ACQUILINE TEST A DFAS-SA/FPA 000 XXXXXXXXXX XXXXXX
XXXXXXXXX XXXXXXX ATTN:MCMR-RMI-S PHONE: 000-000-0000
BLDG 504XX SAN ANTONIO TX 78215-2100
FORT XXXXXXX MD 21702
--------------------------------------------------------------------------------
13. AUTHORITY FOR USING OTHER THAN 14. ACCOUNTING AND APPROPRIATION DATA
FULL AND OPEN COMPETITION:
|_| 10 U.S.C. 2304(c)( ) See Schedule
|_| 41 U.S.C. 253(c)( )
--------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------
15A. ITEM NO. 15B. SUPPLIES/SERVICES 15C. QUANTITY 15D. UNIT 15E. UNIT PRICE 15F. AMOUNT
------------------------------------------------------------------------------------------------------
SEE SCHEDULE
------------------------------------------------------------------------------------------------------
15G. TOTAL AMOUNT OF CONTRACT $1,640,883.00
------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------
16. TABLE OF CONTENTS
--------------------------------------------------------------------------------
(X) SEC. DESCRIPTION PAGE(S)
--------------------------------------------------------------------------------
PART 1 - THE SCHEDULE
--------------------------------------------------------------------------------
X A SOLICITATION/CONTRACT FORM 1
--------------------------------------------------------------------------------
X B SUPPLIES OR SERVICES AND PRICES/COSTS 2
--------------------------------------------------------------------------------
X C DESCRIPTION/SPECS./WORK STATEMENT 3 - 9
--------------------------------------------------------------------------------
D PACKAGING AND MARKING
--------------------------------------------------------------------------------
X E INSPECTION AND ACCEPTANCE 10
--------------------------------------------------------------------------------
X F DELIVERIES OR PERFORMANCE 11 - 15
--------------------------------------------------------------------------------
X G CONTRACT ADMINISTRATION DATA 16 - 17
--------------------------------------------------------------------------------
H SPECIAL CONTRACT REQUIREMENTS
--------------------------------------------------------------------------------
PART II - CONTRACT CLAUSES
--------------------------------------------------------------------------------
X I CONTRACT CLAUSES 18 - 20
--------------------------------------------------------------------------------
PART III - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS
--------------------------------------------------------------------------------
J LIST OF ATTACHMENTS
--------------------------------------------------------------------------------
PART IV - REPRESENTATIONS AND INSTRUCTIONS
--------------------------------------------------------------------------------
K REPRESENTATIONS, CERTIFICATIONS AND
OTHER STATEMENTS OF OFFERORS
--------------------------------------------------------------------------------
L INSTRS., CONDS., AND NOTICES TO OFFERORS
--------------------------------------------------------------------------------
M EVALUATION FACTORS FOR AWARD
--------------------------------------------------------------------------------
CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE
--------------------------------------------------------------------------------
17. |_| CONTRACTOR'S NEGOTIATED AGREEMENT Contractor is required to sign this
document and return copies to issuing office.) Contractor agrees to furnish
and deliver all items or perform all the services set forth or otherwise
identified above and on any continuation sheets for the consideration stated
herein. The rights and obligations of the parties to this contract shall be
subject to and governed by the following documents: (a) this award/contract,
(b) the solicitation, if any, and (c) such provisions, representations,
certifications, and specifications, as are attached or incorporated by reference
herein.
(Attachments are listed herein.)
--------------------------------------------------------------------------------
18. |_| AWARD (Contractor is not required to sign this document.) Your offer
on Solicitation Number ________________ including the additions or changes made
by you which additions or changes are set forth in full above, is hereby
accepted as to the items listed above and on any continuation sheets. This award
consummates the contract which consists of the following documents: (a) the
Government's solicitation and your offer, and (b) this award/contract. No
further contractual document is necessary.
--------------------------------------------------------------------------------
19A. NAME AND TITLE OF SIGNER 20A. NAME AND TITLE OF CONTRACTING
(Type or print) OFFICER
XXXXXXXX X. XXXXXX/CONTRACTING OFFICER
TEL: 000-000-0000
EMAIL: xxxxxxxx.xxxxxx@xxxxx.xxxx.xx
--------------------------------------------------------------------------------
19B. NAME OF CONTRACTOR 19C. DATE SIGNED
BY _____________________________________
(Signature of person authorized to sign)
--------------------------------------------------------------------------------
20B. UNITED STATES OF AMERICA 20C. DATE SIGNED
BY /s/ Xxxxxxxx X. Xxxxxx 12-Dec-2002
--------------------------------------
(Signature of Contracting Officer)
--------------------------------------------------------------------------------
NSN 7540-01-152-8069 26-107 STANDARD FORM 26 (REV. 4-85)
PREVIOUS EDITION UNUSABLE GPO 1985 O - 469-794 Prescribed by GSA
FAR (48 CFR) 53.214(a)
DAMD17-03-C-0040
Page 2 of 20
Section B - Supplies or Services and Prices
ITEM NO SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT
001
COST
Research Proposal entitled, "SmallPox Antiviral Drug"
PURCHASE REQUEST NUMBER: W23RYX-2331-N643
ESTIMATED COST $1,640,883.00
ACRN AA Funded Amount $364,642.00
FOB: Destination
DAMD17-03-C-0040
Page 3 of 20
Section C - Description and Specifications
STATEMENT OF WORK
The contractor shall furnish the necessary equipment, personnel, facilities, and
supplies necessary to conduct studies on the research proposal entitled,
"Smallpox AntiViral Drug" in accordance with Section C, the contractor's
statement of work on pages 4-5 of the research proposal dated 15 May 2002 and
the revised budget dated 22 November 2002, which are incorporated herein by
reference.
TERM OF CONTRACT: 1 January 2003-31 May 2007 (Research to be completed by 31
December 2006).
AMOUNT ALLOTTED TO CONTRACT TO DATE: $364,642
TOTAL AMOUNT OF CONTRACT: $1,640,883
PRINCIPAL INVESTIGATOR: Xx. Xxxxxx X. Xxxxx
TYPE OF CONTRACT: Cost Price Contract
CLAUSES INCORPORATED BY FULL TEXT
REPRESENTATIONS AND CERTIFICATIONS (MAR 1999) (USAMRAA)
The representations, certifications, and other statements submitted by the
contractor, dated 22 November 2002, are incorporated herein by reference.
PRINCIPAL INVESTIGATOR (MAR 1999) (USAMRAA)
The Principal Investigator for this contract is Xxxxxx X. Xxxxx. This individual
shall be continuously responsible for the conduct of the research project. The
contractor shall obtain the Contracting Officer's approval to change the
Principal Investigator or to continue the research work during a continuous
period in excess of three months without the participation of an approved
Principal Investigator. This contract is based on the Principal Investigator
devoting 10% of effort to the project over the term of the contract. The
contractor shall advise the Contracting Officer if the Principal Investigator
will, or plans to, devote substantially less effort to the work than estimated
in the contractor's proposal. A curriculum vitae shall be provided for
professional associates added to the research project or substituted during the
course of work.
USE OF TECHNICAL REFERENCE FACILITY (MAR 1999) (USAMRAA)
The contractor agrees to use, to the extent practical, the technical reference
facilities of the Defense Technical Information Center, 0000 Xxxx X. Xxxxxxx
Xxxx, Xxxxx 0000, Xxxx Xxxxxxx, XX 00000-0000 for the purpose of surveying
existing knowledge and avoiding needless duplication of scientific and
engineering effort and the expenditure thereby represented. All other sources,
whether or not Government controlled, shall be consulted for the same purpose.
DAMD17-03-C-0040
Page 4 of 20
INVESTIGATING AND REPORTING POSSIBLE SCIENTIFIC MISCONDUCT (MAR 1999) (USAMRAA)
a. "Misconduct" or "Misconduct in Science" is defined as fabrication,
falsification, plagiarism, or other practices that seriously deviate from those
that are commonly accepted within the scientific community for proposing,
conducting or reporting research. It does not include honest error or honest
differences in interpretations or judgments of data.
b. Contractors shall xxxxxx a research environment that prevents misconduct in
all research and that deals forthrightly with possible misconduct associated
with research for which U.S. Army Medical Research and Materiel Command funds
have been provided or requested.
c. The contractor agrees to:
(1) Establish and keep current an administrative process to review, investigate,
and report allegations of misconduct in science in connection with research
conducted by the contractor,
(2) Comply with its own administrative process;
(3) Inform its scientific and administrative staff of the policies and
procedures and the importance of compliance with those policies and procedures;
(4) Take immediate and appropriate action as soon as misconduct on the part of
employees or persons within the organization's control is suspected or alleged;
and
(5) Report to the Administrative Contracting Officer (ACO) a decision to
initiate an investigation into possible scientific misconduct.
d. The contractor is responsible for notifying the ACO of appropriate action
taken if at any stage of an inquiry or investigation any of the following
conditions exist:
(1) An immediate health hazard is involved;
(2) There is an immediate need to protect Federal funds or equipment;
(3) A probability exists that the alleged incident will be reported publicly; or
(4) There is a reasonable indication of possible criminal violation.
EMERGENCY COORDINATION AND REPORTING (BDRP) (MAR 1999) (USAMRAA)
a. The contractor shall review the Emergency Response Plan/Safety Program Plan
annually, during the month of July, in consultation with each participating
external support agency. The Emergency Response Plan shall be formally revised,
where necessary, to incorporate current emergency support requirements. The
revised Emergency Response Plan (with the agreements for emergency support as
appendices) shall be formalized in writing. A copy of the revision shall be
retained in your organizational safety office.
b. The contractor shall submit a letter report documenting the outcome of the
annual review of its Emergency Response Plan. The report shall include the dates
of the annual review and coordination, and shall identify and describe all
provisions that represent changes to the initial Emergency Response Plan or the
previous year's annual report. The report shall be submitted no later than
August 1 of each year, beginning with the first August during the performance of
your contract.
c. All reports identified in this provision shall be submitted to the following
address:
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RCQ-S
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx, Xxxxxxxx 00000-0000
ETIOLOGIC AGENTS--BIOLOGICAL DEFENSE RESEARCH PROGRAM (MAR 1999) (USAMRAA)
a. For purpose of this contract etiologic agent--biological defense program is
defined as: any viable microorganism, or its toxin which causes or may cause
human disease, including those agents listed in 42 CFR 723 of the Department of
Health and Human Services regulations, and any agent of biological origin that
poses a degree of
DAMD17-03-C-0040
Page 5 of 20
xxxxxx to those agents and is further identified by the U.S. Army as a threat
agent. The contractor shall comply with the following when working with
etiologic agents:
1. 29 Code of Federal Regulations 1910
2. Occupational Health Standards, and the U.S. Department of Health and Human
Services (DHHS)
3. DHHS Publication No. 93-8395, Biosafety in Microbiological and Biomedical
Laboratories, 1993, as amended
4. 32 CFR 626 Biological Defense Safety Program
5. 32 CFR 627 Biological Defense Safety Program b. Etiologic agents shall be
packaged, labeled, shipped, and transported in accordance with applicable
Federal, state and local laws and regulations, to include:
1. 42 CFR 72 (Interstate Shipment of Etiologic Agents)
2. 49 CFR 172 and 173 (Department of Transportation)
3. 9 CFR 122 (USDA Restricted Animal Pathogens)
4. International Air Transport Association Dangerous Goods Regulations.
5. The United States Postal Service shall not be used for transportation of BDRP
activities involving etiologic agents.
CONTRACTOR SAFETY AND REPORTING (BDRP) (MAR 1999) (USAMRAA)
a. The contractor shall operate under established safety programs for all
biosafety levels of work as identified in the Safety Program Plan, which is
incorporated in this contract. These safety programs shall ensure that
personnel, facilities, and the environment are protected from accidents and
hazardous exposures.
b. The contractor shall conduct this contract work under established operating
procedures which ensure that all individuals who have access to areas for
storage, handling, and disposal of etiologic agents are trained and are
thoroughly familiar with safety requirements. Such procedures shall assure full
compliance with the regulatory standards cited above.
c. The contractor shall conduct an inspection and report the results of all
required biosafety inspections for all Research, Development, Test, or
Evaluation work in accordance with the below listed timeframes. As a minimum the
safety inspections shall address those factors identified in the Safety Program
Plan.
1. For Biosafety Level (BL) 1 and 2:
Time Inspector
Xxxxxxxx Government designated Biosafety
Officer
Quarterly First line supervisor
Annual Contractor safety personnel
2. For Biosafety Level (BL) 3:
Time Inspector
Preaward Government designated Biosafety
Officer
Monthly First line supervisor
Annual Government designated Bisafety
Officer
3. For Biosafety Level (BL) 4:
Time Inspector
Preaward Government designated Biosafety
Officer
Monthly First line supervisor
Semiannual Government designated Biosafety
Officer
4. Copies of all biosafety inspection reports will be
DAMD17-03-C-0040
Page 6 of 20
distributed as follows:
Original:
In the contractor's records (Retained for at least three years)
One copy to the following:
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RCQ-S
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx, Xxxxxxxx 00000-0000
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-PLD
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx, Xxxxxxxx 00000-0000
U.S. Army Medical Research Acquisition Activity
ATTN: MCMR-AAA
000 Xxxxxxxx Xxxxxx
Xxxx Xxxxxxx, Xxxxxxxx 00000-0000
PROHIBITION OF USE OF HUMAN SUBJECTS (NOV 2000) (USAMRAA)
Notwithstanding any other provisions contained in this award or incorporated by
reference herein, the contractor is expressly forbidden to use or subcontract
for the use of human subjects in any manner whatsoever. In the performance of
this award, the contractor agrees not to come into contact with, use or employ,
or subcontract for the use or employ of any human subjects for research,
experimentation, tests or other treatment under the scope of work as set out in
the award
USE OF LABORATORY ANIMALS (CONUS)(MAR 2002) (USAMRAA)
a. The contractor or its subcontractors, are authorized to conduct
research under this award involving laboratory animals for the following
protocols:
Protocol entitled, "Smallpox Antiviral Drug" submItted by Xx. Xxxxxx Xxxxx
for the use of mice,
b. ANIMAL WELFARE
(1) For those facilities that are required to do so by federal law, the
contractor shall register its research facility with the Secretary of
Agriculture in accordance with 7 U.S.C. 2136 and 9 CFR, Subchapter A, Part 2,
Subpart C, and Section 2.30.
(2) The contractor shall acquire regulated animals only from dealers
licensed by the Secretary of Agriculture under 7 U.S.C. 2133 and 9 CFR,
Subchapter A, Part 2, Subpart A, Sections 2.1 through 2.11, or from sources that
are exempt from licensing under those sections.
(3) The contractor agrees that the care and use of animals will conform
DAMD17-03-C-0040
Page 7 of 20
with the pertinent laws of the United States and regulations of the Department
of Agriculture (see 7 U.S.C. 2131 et.seq. and 9 CFR Subchapter A, Parts I
through 4), and that the research will adhere to the principles set forth in the
Guide for Care and Use of Laboratory Animals, National Research Council, 1996.
(4) The Contracting Officer may immediately suspend, in whole or in part,
work and further payments under this award for failure to comply with the
requirements of paragraphs (1) through (3) of this clause.
(a) The suspension will stay in effect until the contractor complies
with the requirements.
(b) Failure to complete corrective action within the time specified
by the Contracting Officer may result in termination of this award and removal
of the contractor's name from the list of facilities approved for funding.
(5) The contractor may request registration of its facility and a current
listing of licensed dealers from the Regional Office of the Animal and Plant
Health Inspection Service (APHIS), United States Department of Agriculture
(USDA), for the region in which its research facility is located. The location
of the appropriate APHIS regional office, as well as information concerning this
program may be obtained by contacting the Senior Staff Officer, Animal Care
Staff, USDA/APHIS, Animal Care, 4700 River Road, Unit 84, Riverdale, MD
00000-0000 (Phone number 000-000-0000 or email xxx@xxxx.xxx).
(6) The contractor shall include this clause, including this paragraph
(6), in all subcontracts/subawards involving research of live vertebrate
animals.
c. POST-AWARD OVERSIGHT OF THE USE OF LABORATORY ANIMALS
Post-award oversight of the use of laboratory animals shall be the
responsibility of the contractor's Animal Care and Use Committee (ACUC). The
Principal Investigator will notify the Contracting Officer in writing of any
significant changes to the proposed use of animals which was the basis for
award. These changes must be approved by the contractor's ACUC and the USAMRMC.
In addition, the ACUC shall immediately notify the Contracting Officer of any
violations of law, or regulation involving animal care, or of changes in the
facility's accreditation status by the Association for the Assessment and
Accreditation of Laboratory Animal Care, International (AAALAC).
d. ANIMAL USE REPORTING
(1) The contractor shall annually prepare and electronically submit the
U.S. Army Medical Research and Materiel Command Animal Use Report detailing the
use of animals in the research and development sponsored by the Army. The web
site containing information for electronic submission of this report may be
found at xxxx://xxx.xxxxxxx.xxxx.xxx.
(2) A letter with additional instructions concerning use of the electronic
web site will be mailed at the end of the fiscal year. The reporting period
shall be each Federal Fiscal Year, i.e., 01 October through 30 September, and
the report shall be electronically received by the U.S. Army Medical Research
and Materiel Command no later than 1 December of that year.
(3) For awards with expiration dates prior to 30 September, instructions
for submission of the final animal use report may be found at
xxxx://xxx.xxxxxxx.xxxx.xxx.
(4) The contractor shall also furnish a copy of the most recent USDA
Inspection Report. This report can be submitted via fax or mail to:
DAMD17-03-C-0040
Page 8 of 20
Commander
U.S. Army Medical Research & Materiel Command
ATTN: MCMR-RCQ-AR
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx XX 00000-0000
FAX: (000) 000-0000
(5) The contractor is responsible for ensuring that a separate U.S.
Army Medical Research and Materiel Command Animal Use Report and USDA Inspection
Report be submitted for any subcontract/subaward facility).
PROHIBITION OF USE OF HUMAN ANATOMICAL SUBSTANCES (NOV 2000) (USAMRAA)
Notwithstanding any other provisions contained in this award or incorporated by
reference herein, the contractor is expressly forbidden to use or subcontract
for the use of human anatomical substances in any manner whatsoever. In the
performance of this award, the contractor agrees not to come into contact with,
use or employ, or subcontract for the use or employ of any human anatomical
substances for research, experimentation, tests or other treatment under the
scope of work as set out in the award.
REPORTS, MANUSCRIPTS AND PUBLIC RELEASES (MAR 1999) (USAMRAA)
a. Contractors are encouraged to publish results of research supported by
USAMRMC in appropriate media forum. Any publication, report or public release,
which may create a statutory bar to the issuance of a patent on any subject
invention, shall be coordinated with appropriate patent counsel.
b. Manuscripts intended for publication in any media shall be submitted to the
COR, simultaneously with submission for publication. Review of such manuscripts
is for comment to the Principal Investigator, not for approval or disapproval.
Xxxxxxxx copies of the reprint shall be forwarded to the COR, even though
publication may be subsequent to the expiration of the contract.
c. The contractor shall notify the Contracting Officer of planned news releases,
planned publicity, advertising material concerning contract work, and planned
presentations to scientific meetings prior to public release. This is not
intended to restrict dissemination of research information but to allow the U.S.
Army Medical Research and Materiel Command (USAMRMC) advance notice in order to
adequately respond to inquiries.
d. Manuscripts, reports, public releases and abstracts, which appear in
professional journals, media and programs, shall include the following
statements:
(1) "This work is supported by the U.S. Army Medical Research and Materiel
Command under Contract No. DAMD17-03-C-40."
(2) "The views, opinions and/or findings contained in this report are those of
the author(s) and should not be construed as an official Department of the Army
position, policy or decision unless so designated by other documentation."
(3) "In conducting research using animals, the investigator(s) adhered to the
"Guide for the Care and Use of Laboratory Animals," prepared by the Committee on
Care and Use of Laboratory Animals of the Institute of Laboratory Animal
Resources, National Research Council (NIH Publication No. 86-23, Revised 1985)."
(4) "In the conduct of research where humans are the subjects, the
investigator(s) adhered to the policies regarding the protection of human
subjects as prescribed by 45 CFR 46 and 32 CFR 219 (Protection of Human
Subjects)."
DAMD17-03-C-0040
Page 9 of 20
(5) In conducting work involving the use of recombinant DNA the investigator(s)
adhered to Guidelines for Research Involving Recombinant DNA Molecules; Notice,
Federal Register, July 5, 1994, Volume 59, Number 127.
DAMD17-03-C-0040
Page 10 of 20
Section E - Inspection and Acceptance
CLAUSES INCORPORATED BY REFERENCE
52.246-8 Inspection Of Research And Development Cost MAY 2001
Reimbursement
DAMD17-03-C-0040
Page 11 of 20
Section F - Deliveries or Performance
PERFORMANCE
a. The period of performance for this contract is 1 January 2003 through
31 May 2007 (Research ends 31 December 2006). The research required by the
statement of work in Section C shall be conducted during the period 1 Jan 2003
through 31 December 2006. The additional month is to allow sufficient time to
complete the final reports.
CLAUSES INCORPORATED BY REFERENCE
52.242-15 Stop-Work Order AUG 1989
52.247-34 F.O.B. Destination NOV 1991
REPORTING REQUIREMENT
QUARTERLY REPORTS FORMAT (OCT 1992) (USAMRAA)
a. Quarterly reports are the most immediate and direct contact between the
Principal Investigator (PI) and the Contracting Officer's Representative (COR).
The reports provide the means for keeping this Command advised of developments
and problems as the contract effort proceeds. The quarterly reports also provide
a measure against which decisions on release of funding and on requests for
supplements are made.
b. Quarterly reports shall be submitted for each three-month period of the
contract beginning with the effective date of the contract. This requirement
includes all three-month periods of the contract.
c. Copies of each report shall be submitted in the quantities indicated to the
addresses shown below within fifteen (15) days after the end of each quarter.
Internal Government distribution will be made by those offices.
(1) Two (2) copies of the report to:
X.X.Xxxx Medical Research Institute for Infectious Diseases (USAMRIID)
ATTN: Xx. Xxx Xxxxxx
0000 Xxxxxx Xxxxxx
Xxxx Xxxxxxx, XX 00000
(2) Three (3) copies of the report to:
Commander
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RMI-S
000 Xxxxx Xxxxxx
Xxxx Xxxxxxx, XX 00000-0000
(3) One (1) copy of the report to:
Director
U. S. Army Medical Research Acquisition Activity (USAMRAA)
ATTN: MCMR-AAA-A
000 Xxxxxxxx Xxxxxx
Xxxx Xxxxxxx, XX 00000-0000
DAMD17-03-C-0040
Page 12 of 20
d. Photocopies of the blank Quarterly report sample shown on the following page
shall serve as the format. Each item of the report format shall be completed or
addressed.
DAMD17-03-C-0040
Page 13 of 20
Quarterly Report Format
1. Contract No.__________________________ 2. Report Date _________________
3. Reporting period from ________________ to _____________________________
4. PI____________________________________ 5. Telephone No. _______________
6. Institution__________________________________________________________________
7. Project Title: ______________________________________________________________
________________________________________________________________________________
8. Current staff, with percent effort of each on project.
________________________________% _____________________________%
________________________________% _____________________________%
9. Contract expenditures to date (as applicable):
This Qtr/Cumulative
Personnel______________________________/_____________________________
Travel_________________________________/_____________________________
Fringe Benefits________________________/_____________________________
Equipment______________________________/_____________________________
Supplies_______________________________/________________ Other__________________
This Qtr/Cumulative
Subtotal_______________________________/_____________________________
Indirect Costs_________________________/_____________________________
Fee____________________________________/_____________________________
Total:_________________________________/________________________ ____
10. Comments on administrative and logistical matters.
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
11. Use additional page(s), as necessary, to describe scientific progress for
the quarter in terms of the tasks or objectives listed in the statement of work
for this contract. Explain deviations where this isn't possible. Include data
where possible.
12. Use additional page(s) to present a brief statement of plans or milestones
for the next quarter.
DAMD17-03-C-0040
Page 14 of 20
RESEARCH TECHNICAL REPORTING REQUIREMENTS (NOV 2000) (USAMRAA)
Format Requirements for Annual/Final Reports
a. Annual reports must provide a complete summary of the research
accomplishments to date with respect to the approved Statement of Work. Journal
articles can be substituted for detailed descriptions of specific aspects of the
research, but the original articles must be attached to the report as an
appendix and appropriately referenced in the text. The importance of the report
to decisions relating to continued support of the research can not be
overemphasized. A report shall be submitted within 30 calendar days of the
anniversary date of the award (a final report will be submitted upon completion
of the research (last year of the award)).
b. A final report summarizing the entire research effort, citing data in
the annual reports and appended publications shall be submitted at the end of
the award performance period. The final report will provide a complete reporting
of the research findings. Journal publications can be substituted for detailed
descriptions of specific aspects of the research, but an original copy of each
publication must be attached as an appendix and appropriately referenced in the
text. All final reports must include a bibliography of all publications and
meeting abstracts and a list of personnel (not salaries) receiving pay from the
research effort.
c. Although there is no page limitation for the reports, each report shall
be of sufficient length to provide a thorough description of the accomplishments
with respect to the approved Statement of Work. Submission of an original and
two copies of the report are required. Reports shall be forwarded to:
Commander
U.S. Army Medical Research and Materiel Command
ATTN: MCMR-RMI-S
000 Xxxxx Xxxxxx Xxxx Xxxxxxx,
Xxxxxxxx 00000-0000
d. All reports shall have the following elements in this order: front
cover, Standard Form (SF 298), table of contents, introduction, body, key
research accomplishments, reportable outcomes, conclusions, references, and
appendices. Pages shall be consecutively numbered throughout the report. DO NOT
RENUMBER PAGES IN THE APPENDICES BUT DO INCLUDE THE APPENDICES IN THE PAGE COUNT
IN BLOCK 15 ON THE SF 298. Mark all pages of the report which contain
proprietary or unpublished data that should be protected. DO NOT USE THE WORD
"CONFIDENTIAL" WHEN MARKING DOCUMENTS. Indicate in your letter accompanying the
report that the report contains proprietary or unpublished data, and that the
distribution statement should indicate the limitations of the report.
FRONT COVER: Sample front cover provided at xxxx://xxxx-xxx.xxxx.xxx. The
Accession Document (AD) Number should remain blank.
STANDARD FORM 298: Sample SF 298 provided at xxxx://xxxx-xxx.xxxx.xxx. Go to
site index and click on Research Reports and click on SF298 for a copy. The
abstract in Block 13 must state the purpose, scope, major findings and be an
up-to-date report of the progress in terms of results and significance. Subject
terms are keywords that may have previously assigned to the proposal abstract or
are keywords that may be significant to the research. The number of pages shall
include all pages that have printed data (including the front cover, SF 298,
table of contents, and all appendices). Please count pages carefully to ensure
legibility and that there are no missing pages as this delays processing of
reports. Page numbers should be typed: please do not hand number pages.
TABLE OF CONTENTS: Sample table of contents provided at
xxxx://xxxx-xxx.xxxx.xxx.
INTRODUCTION: Narrative that briefly (one paragraph) describes the subject,
purpose and scope of the research.
DAMD17-03-C-0040
Page 15 of 20
BODY: This section of the report shall describe the research accomplishments
associated with each task outlined in the approved Statement of Work. Data
presentation shall be comprehensive in providing a complete record of the
research findings for the period of the report. Appended publications and/or
presentations may be substituted for detailed descriptions but must be
referenced in the body of the report. If applicable, for each task outlined in
the Statement of Work, reference appended publications and/or presentations for
details of result findings and tables and/or figures. The report shall include
negative as well as positive findings. Include problems in accomplishing any of
the tasks. Statistical tests of significance shall be applied to all data
whenever possible. Figures and graphs referenced in the text may be embedded in
the text or appended. Figures and graphs can also be referenced in the text and
appended to a publication. Recommended changes or future work to better address
the research topic may also be included, although changes to the original
Statement of Work must be approved by the Grants Officer. This approval must be
obtained prior to initiating any change to the original Statement of Work.
KEY RESEARCH ACCOMPLISHMENTS: Bulleted list of key research accomplishments
emanating from this research.
REPORTABLE OUTCOMES: Provide a list of reportable outcomes that have resulted
from this research to include:
manuscripts, abstracts, presentations; patents and
licenses applied for and/or issued; degrees obtained
that are supported by this award; development of
cell lines, tissue or serum repositories; infomatics
such as databases and animal models, etc.; funding
applied for based on work supported by this award;
employment or research opportunities applied for
and/or received based on experience/training
supported by this award.
CONCLUSIONS: Xxxxxxxxx the results to include the Importance and/or implications
of the completed research and when necessary, recommend changes on future work
to better address the problem. A "so what section" which evaluates the knowledge
as a scientific or medical product shall also be included in the conclusion of
the report.
REFERENCES: List all references pertinent to the report using a standard journal
format (i.e. format used in Science, Military Medicine, etc.).
APPENDICES: Attach all appendices that contain information that supplements,
clarifies or supports the text. Examples include original copies of journal
articles, reprints of manuscripts and abstracts, a curriculum vitae, patent
applications, study questionnaires, and surveys, etc.
BINDING: Because all reports are entered into the Department of Defense
Technical Reports database collection and are microfiched, it is recommended
that all reports be bound by stapling the pages together in the upper left hand
corner. All original reports shall be legible and contain original
photos/illustrations. Figures shall include figure legends and be clearly marked
with figure numbers.
DAMD17-03-C-0040
Page 16 of 20
Section G - Contract Administration Data
ACCOUNTING AND APPROPRIATION DATA
AA: 97204002601074811930603384BPO255YP1FFKAW23RYX2331N643FFKAP1018064
AMOUNT: $364,642.00
CLAUSES INCORPORATED BY FULL TEXT
INCREMENTAL FUNDING (MAR 1999) (USAMRAA)
a. It is estimated that the total cost to the Government for the full
performance of this contract for the period 1 January 2003 to 31 May 2007 will
be $1,640,883.00 There have been funds allotted for reimbursement of allowable
costs, and applicable fee, incurred in the performance of this contract in the
amount of only $364,642.00. It is estimated that such funded amount shall be
sufficient to cover allowable expenses for the period 1 Jan 2003 to 31 Dec 2004.
The amount of the funds currently allotted may be increased by the Contracting
Officer without further concurrence of the contractor. It is estimated that the
remaining funds will be made available in accordance with the following
schedule:
Amount On or about
$413,424 1 January 2004
$436,376 1 January 2005
$426,441 1 January 2006
b. Pending the availability of additional funds, performance by the contractor
shall be governed by the contract clause entitled "Limitation of Funds", FAR
52.232-22.
VOUCHERS (MAR 1999) (USAMRAA)
a. The Contractor shall submit an original and one copy of public vouchers (SF
1034) not less frequently than monthly to U.S. Army Medical Research Acquisition
Activity (USAMRAA), Attn: Xxxxxxx Xxxxxx, 000 Xxxxxxxx Xxxxxx, Xxxx Xxxxxxx, XX
00000-5014 for review and forwarding for payment.
b. Voucher categories shall adhere to budget categories listed in the negotiated
budget used for funding the contract. All vouchers shall state the total amount
claimed and the subtotals claimed in the following types of categories: salaries
and wages, overhead stating percentage and base, travel, equipment, supplies,
and any other categories used in the negotiated budget. Suitable detailed
support for amounts claimed shall be shown on continuation sheets. For instance,
direct labor costs should include number of hours worked by individual, hourly
rate, and total. Travel costs should include number of trips, public carrier
rates, per diem costs, incidental costs, etc.
c. Cumulative totals of expenditures in each category shall also be shown.
d. Each voucher submitted must state the period of performance. Each voucher
submitted must request payment for only those man-hours or cost expenditures
incurred in that period.
e. The Contracting Officer shall be notified immediately in the event a budget
category is expected to deviate from the negotiated budget.
f. The completion voucher shall be submitted by the Contractor to the
Contracting Officer.
DAMD17-03-C-0040
Page 17 of 20
TRAVEL (MAR 1999) (USAMRAA)
a. Approval of Foreign Travel. The cost of foreign travel is allowable only when
the specific written approval of the Contracting Officer or Contract Specialist
responsible for administration of the contract is obtained prior to commencing
the trip. Approval must be requested at least 30 days before the scheduled
departure date in order that all necessary clearances may be processed. Each
individual trip must be approved separately even though it may have been
included in a previously approved budget. Foreign travel is defined as any
travel outside of Canada and the United States and its territories and
possessions.
b. Domestic/local travel shall take place in accordance with Department of
Defense Joint Travel Regulations (JTR). Documentation showing dates and mileage
for such travel shall be maintained and furnished in support of invoice claiming
reimbursement.
PROPERTY REPORTING (COMMERCIAL) (MAR 1999) (USAMRAA)
The designated property administrator for Government property acquired for use
under this contract is the Contract Specialist, US Army Medical Research
Acquisition Activity, Fort Xxxxxxx, MD 21702-5014. The contractor shall furnish
the designated property administrator report, (i.e. DD FORM 1662, DOD Property
in the Custody of Contractors).
a. Interim Inventories - Annually, as of 30 September, report due 10 October,
each year.
b. Final Inventory - When the contract expires.
DAMD17-03-C-0040
Page 18 of 20
Section I - Contract Clauses
CLAUSES INCORPORATED BY REFERENCE
52.202-1 Definitions DEC 2001
52.203-3 Gratuities APR 1984
52.203-5 Covenant Against Contingent Fees APR 1984
52.203-6 Restrictions On Subcontractor Sales To The Government JUL 1995
52.203-7 Anti-Kickback Procedures JUL 1995
52.203-8 Cancellation, Rescission, and Recovery of Funds for Illegal or JAN 1997
Improper Activity
52.203-10 Price Or Fee Adjustment For Illegal Or Improper Activity JAN 1997
52.203-12 Limitation On Payments To Influence Certain Federal JUN 1997
Transactions
52.204-4 Printed or Copied Double-Sided on Recycled Paper AUG 2000
52.208-8 Helium Requirement Forecast And Required Sources For APR 2002
Helium
52.209-6 Protecting the Government's Interest When Subcontracting JUL 1995
With Contractors Debarred, Suspended, or Proposed for
Debarment
52.215-2 Alt III Audit and XXXX 1999Negotiation (Jun 1999) Alternate III
52.216-7 Allowable Cost And Payment FEB 2002
52.216-11 Cost Contract--No Fee APR 1984
52.222-3 Convict Labor AUG 1996
52.222-21 Prohibition Of Segregated Facilities FEB 1999
52.222-26 Equal Opportunity APR 2002
52.223-6 Drug Free Workplace MAY 2001
52.223-14 Toxic Chemical Release Reporting OCT 2000
52.225-13 Restrictions on Certain Foreign Purchases JUL 2000
52.228-7 Insurance--Liability To Third Persons MAR 1996
52.232-9 Limitation On Withholding Of Payments APR 1984
52.232-17 Interest JUN 1996
52.232-22 Limitation Of Funds APR 1984
52.232-25 Alt I Prompt Payment (Feb 2002) Alternate I FEB 2002
52.232-33 Payment by Electronic Funds Transfer--Central Contractor MAY 1999
Registration
52.233-1 Disputes JUL 2002
52.233-3 Alt I Protest After Award (Aug 1996) - Alternate I JUN 1985
52.242-13 Bankruptcy JUL 1995
52.243-2 Alt V Changes--Cost-Reimbursement (Aug 1987) - Alternate V APR 1984
52.249-6 Termination (Cost Reimbursement) SEP 1996
52.249-14 Excusable Delays APR 1984
52.253-1 Computer Generated Forms JAN 1991
252.203-7001 Prohibition On Persons Convicted of Fraud or Other Defense- MAR 1999
Contract-Related Felonies
252.204-7003 Control Of Government Personnel Work Product APR 1992
252.204-7004 Required Central Contractor Registration NOV 2001
252.209-7004 Subcontracting With Firms That Are Owned or Controlled By MAR 1998
The Government of a Terrorist Country
252.225-7012 Preference For Certain Domestic Commodities APR 2002
252.225-7026 Reporting Of Contract Performance Outside The United JUN 2000
States
252.227-7034 Patents--Subcontracts APR 1984
DAMD17-03-C-0040
Page 19 of 20
252.227-7039 Patents--Reporting Of Subject Inventions APR 1990
252.235-7011 Final Scientific or Technical Report SEP 1999
252.243-7001 Pricing Of Contract Modifications DEC 1991
252.243-7002 Requests for Equitable Adjustment MAR 1998
252.244-7000 Subcontracts for Commercial Items and Commercial MAR 2000
Components (DoD Contracts)
252.247-7023 Transportation of Supplies by Sea MAY 2002
252.247-7024 Notification Of Transportation Of Supplies By Sea MAR 2000
CLAUSES INCORPORATED BY FULL TEXT
52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force
and effect as if they were given in full text. Upon request, the Contracting
Officer will make their full text available. Also, the full text of a clause may
be accessed electronically at this/these address(es):
xxx.xxxxxxx.xxxx.xxx
(End of clause)
52.252-6 AUTHORIZED DEVIATIONS IN CLAUSES (APR 1984)
(a) The use in this solicitation or contract of any Federal Acquisition
Regulation (48 CFR Chapter 1) clause with an authorized deviation is indicated
by the addition of "(DEVIATION)" after the date of the clause.
b. The use in this solicitation or contract of any Defense Federal Acquisition
Regulation Supplement (48 CFR Chapter 2) clause with an authorized deviation is
indicated by the addition of "(DEVIATION)" after the name of the regulation.
252.235-7002 ANIMAL WELFARE. (DEC 1991)
(a) The Contractor shall register its research facility with the Secretary of
Agriculture in accordance with 7 U.S.C. 2316 and 9 CFR subpart C, and 2.30, and
furnish evidence of such registration to the Contracting Officer before
beginning work under this contract.
(b) The Contractor shall acquire animals only from dealers licensed by the
Secretary of Agriculture under 7 U.S.C. 2133 and 9 CFR subpart A, 2.1 through
2.11, or from sources that are exempt from licensing under those sections.
(c) The Contractor agrees that the care and use of animals will conform with the
pertinent laws of the United States and regulations of the Department of
Agriculture (see 7 U.S.C. 2131 et. seq. and 9 CFR subchapter A, parts 1 through
4).
(d) The Contracting Officer may immediately suspend, in whole or in part, work
and further payments under this contract for failure to comply with the
requirements of paragraphs (a) through (c) of this clause.
(1) The suspension will stay in effect until the Contractor complies with the
requirements.
DAMD17-03-C-0040
Page 20 of 20
(2) Failure to complete corrective action within the time specified by the
Contracting Officer may result in termination of this contract and removal of
the Contractor's name from the list of contractors with approved Public Health
Service Welfare Assurances.
(e) The Contractor may request registration of its facility and a current
listing of licensed dealers from the Regional Office of the Animal and Plant
Health Inspection Service (APHIS), United States Department of Agriculture
(USDA), for the region in which its research facility is located. The location
of the appropriate APHIS regional office, as well as information concerning this
program may be obtained by contacting the Senior Staff Officer, Animal Care
Staff, USDA/APHIS, Federal Center Building, Hyausville, MD 20782.
(f) The Contractor shall include this clause, including this paragraph (f), in
all subcontracts involving research of live vertebrate animals.
252.235-7010 Acknowledgment of Support and Disclaimer. (MAY 1995)
(a) The Contractor shall include an acknowledgment of the Government's support
in the publication of any material based on or developed under this contract,
stated in the following terms: This material is based upon work supported by the
U.S. Army Medical Research Acquisition Activity (USAMRAA) under Contract No.
DAMD17-03-C-0040..
(b) All material, except scientific articles or papers published in scientific
journals, must, in addition to any notices or disclaimers by the Contractor,
also contain the following disclaimer: Any opinions, findings and conclusions or
recommendations expressed in this material are those of the author(s) and do not
necessarily reflect the views of the USAMRAA.
